Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hartl

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|August 10, 2013
Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffoldScott A Bolton, James C Sutton, Rushith Anumula, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577Yan Shi, Chi Li, Stephen P O'Connor, et al.
Scientific Reports|June 11, 2023
Deep learning-assisted radiomics facilitates multimodal prognostication for personalized treatment strategies in low-grade gliomaP Rauch, H Stefanits, M Aichholzer, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
Ketene aminal-based lactam derivatives as a novel class of orally active FXa inhibitorsYan Shi, Jing Zhang, Philip D Stein, et al.
Pulmonology|April 13, 2024
Association between lung function and dyspnoea and its variation in the multinational Burden of Obstructive Lung Disease (BOLD) studyA Müller, E F Wouters, P Koul, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|August 10, 2013
Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffoldScott A Bolton, James C Sutton, Rushith Anumula, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577Yan Shi, Chi Li, Stephen P O'Connor, et al.
Scientific Reports|June 11, 2023
Deep learning-assisted radiomics facilitates multimodal prognostication for personalized treatment strategies in low-grade gliomaP Rauch, H Stefanits, M Aichholzer, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
Ketene aminal-based lactam derivatives as a novel class of orally active FXa inhibitorsYan Shi, Jing Zhang, Philip D Stein, et al.
Pulmonology|April 13, 2024
Association between lung function and dyspnoea and its variation in the multinational Burden of Obstructive Lung Disease (BOLD) studyA Müller, E F Wouters, P Koul, et al.
Pageof 4